-
1.
公开(公告)号:US20110092708A1
公开(公告)日:2011-04-21
申请号:US12376354
申请日:2007-07-31
申请人: Seeta Ramanjaneyulu Gorantla , Mohan Bandari , Venkata Sunil Kumar Indukuri , Srinivas Simhadri , Narasimha Rao Ketavarapu , Venkata Krishna Kishore Jammulaveera , Yaseen Mohammed
发明人: Seeta Ramanjaneyulu Gorantla , Mohan Bandari , Venkata Sunil Kumar Indukuri , Srinivas Simhadri , Narasimha Rao Ketavarapu , Venkata Krishna Kishore Jammulaveera , Yaseen Mohammed
IPC分类号: C07D215/18
CPC分类号: C07D215/18
摘要: The present invention relates to the alkyl amine salts of Montelukast and methods for their preparation and conversion of Montelukast amine salts to Montelukast or Montelukast alkali/alkaline salt.
摘要翻译: 本发明涉及孟鲁司特坦的烷基胺盐及其制备和转化孟鲁司特胺盐至孟鲁司特或蒙特鲁卡斯特碱/碱性盐的方法。
-
公开(公告)号:US08344159B2
公开(公告)日:2013-01-01
申请号:US12304645
申请日:2007-06-11
申请人: Seeta Ramanjaneyulu Gorantla , Mohan Bandari , Nageshwara Rao Karusala , Sankara Sastry Tummalapalli Uma
发明人: Seeta Ramanjaneyulu Gorantla , Mohan Bandari , Nageshwara Rao Karusala , Sankara Sastry Tummalapalli Uma
IPC分类号: C07D209/88
CPC分类号: C07D209/88
摘要: The present invention relates a novel crystalline 1-(Carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol phosphate sesquihydrate (Carvedilol dihydrogenphosphate sesquihydrate), methods of preparing the sesquihydrate by adding phosphoric acid to a suspension of Carvedilol in water, water miscible solvents or a mixture of water and water miscible organic solvent followed by isolating the product directly or by adding solvent.
摘要翻译: 本发明涉及一种新的1-(恶唑-4-基氧基-3 - [[2-(邻甲氧基苯氧基)乙基]氨基] -2-丙醇磷酸倍半水合物(卡维地洛二氢磷酸倍半水合物)的结晶,通过加入制备倍半水合物的方法 磷酸与卡维地洛在水中的混悬液,水溶性溶剂或水与水混溶的有机溶剂的混合物,然后直接或通过加入溶剂分离产物。
-
公开(公告)号:US20110034701A1
公开(公告)日:2011-02-10
申请号:US12445105
申请日:2007-10-09
申请人: Dutt Tyagi Om , Nageswara Rao Karusala , Uma Sankara Sastry Tummalapalli , Mohan Bandari , Seeta Ramanjaneyulu Gorantla
发明人: Dutt Tyagi Om , Nageswara Rao Karusala , Uma Sankara Sastry Tummalapalli , Mohan Bandari , Seeta Ramanjaneyulu Gorantla
IPC分类号: C07D403/10
CPC分类号: C07D403/10
摘要: Present invention is to provide one pot synthesis of candesartan without isolating the ester intermediate.
摘要翻译: 本发明是提供一种不分离酯中间体的坎地沙坦一锅合成。
-
公开(公告)号:US20090259051A1
公开(公告)日:2009-10-15
申请号:US12304645
申请日:2007-06-11
申请人: Seeta Ramanjaneyulu Gorantla , Mohan Bandari , Nageswara Rao Karusala , Sankara Sastry Tummalapalli
发明人: Seeta Ramanjaneyulu Gorantla , Mohan Bandari , Nageswara Rao Karusala , Sankara Sastry Tummalapalli
IPC分类号: C07D209/82 , A61P9/12
CPC分类号: C07D209/88
摘要: The present invention relates a novel crystalline 1-(Carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol phosphate sesquihydrate (Carvedilol dihydrogenphosphate sesquihydrate), methods of preparing the sesquihydrate by adding phosphoric acid to a suspension of Carvedilol in water, water miscible solvents or a mixture of water and water miscible organic solvent followed by isolating the product directly or by adding solvent.
摘要翻译: 本发明涉及一种新的1-(恶唑-4-基氧基-3 - [[2-(邻甲氧基苯氧基)乙基]氨基] -2-丙醇磷酸倍半水合物(卡维地洛二氢磷酸倍半水合物)的结晶,通过加入制备倍半水合物的方法 磷酸与卡维地洛在水中的混悬液,水溶性溶剂或水与水混溶的有机溶剂的混合物,然后直接或通过加入溶剂分离产物。
-
公开(公告)号:US20090240064A1
公开(公告)日:2009-09-24
申请号:US12280263
申请日:2007-02-20
申请人: Venkata Panakala Rao Gogulapati , Ramdas Chavakula , Mohan Bandari , Seeta Ramanjaneyulu Gorantla
发明人: Venkata Panakala Rao Gogulapati , Ramdas Chavakula , Mohan Bandari , Seeta Ramanjaneyulu Gorantla
IPC分类号: C07D207/30
CPC分类号: C07D207/34
摘要: The present invention relates to a new crystalline form of Atorvastatin hemi-calcium and also relates to a process for preparation of the same by treating Atorvastatin hemi-calcium amorphous form or form-I or mixture of amorphous and crystalline forms with methanol.
摘要翻译: 本发明涉及阿托伐他汀半钙的新结晶形式,还涉及通过用甲醇处理阿托伐他汀半钙无定形形式或形式I或无定形和结晶形式的混合物来制备该方法。
-
公开(公告)号:US08143435B2
公开(公告)日:2012-03-27
申请号:US12445105
申请日:2007-10-09
申请人: Dutt Tyagi Om , Nageswara Rao Karusala , Uma Sankara Sastry Tummalapalli , Mohan Bandari , Seeta Ramanjaneyulu Gorantla
发明人: Dutt Tyagi Om , Nageswara Rao Karusala , Uma Sankara Sastry Tummalapalli , Mohan Bandari , Seeta Ramanjaneyulu Gorantla
IPC分类号: C07C255/00
CPC分类号: C07D403/10
摘要: Present invention is to provide one pot synthesis of candesartan without isolating the ester intermediate.
摘要翻译: 本发明是提供一种不分离酯中间体的坎地沙坦一锅合成。
-
公开(公告)号:US20090062550A1
公开(公告)日:2009-03-05
申请号:US12093683
申请日:2006-11-14
IPC分类号: C07D249/08
CPC分类号: C07D403/06
摘要: The present invention provides a method for preparing pure Rizatriptan benzoate having purity more than 99.5% and dimer impurity less than 0.1% comprises, i) Condensation of 1,2,4-Triazole with 4-Nitro benzyl bromide to yield 1-(4-nitrophenyl)methyl-1,2,4-triazole ii) Reducing the 1-(4-nitrophenyl)methyl-1,2,4-triazole to give 1-(4-aminophenyl)methyl-1,2,4-triazole iii) Converting 1-(4-aminophenyl)methyl-1,2,4-triazole to 1-(4-hydrazinophenyl)methyl-1,2,4-triazole hydrochloride iv) Condensing the hydrazine derivative with 4-(Dimethylamino) butanal diethylacetal to get Rizatriptan and v) Salification of Rizatriptan to Rizatriptan benzoate.
摘要翻译: 本发明提供一种制备纯度大于99.5%,二聚体杂质小于0.1%的纯粹利扎曲普坦苯甲酸酯的方法,包括:i)1,2,4-三唑与4-硝基苄基溴的缩合,得到1-(4- 硝基苯基)甲基-1,2,4-三唑ii)还原1-(4-硝基苯基)甲基-1,2,4-三唑,得到1-(4-氨基苯基)甲基-1,2,4-三唑iii )将1-(4-氨基苯基)甲基-1,2,4-三唑转化为1-(4-肼基苯基)甲基-1,2,4-三唑盐酸盐iv)将肼衍生物与4-(二甲基氨基)丁醛二乙缩醛缩合 获得利扎曲坦和v)利扎曲坦对盐酸利扎曲坦的盐化。
-
公开(公告)号:US07943780B2
公开(公告)日:2011-05-17
申请号:US12279226
申请日:2007-02-14
IPC分类号: C07D257/00
CPC分类号: C07D403/10
摘要: The invention relates to process for the preparation of Candesartan cilexetil. More particularly, it relates to the preparation of pure candesartan cilexetil by the deprotection of Trityl candesartan cilexetil with inorganic acids.
摘要翻译: 本发明涉及制备Candesartan cilexetil的方法。 更具体地说,它涉及通过三苯甲基坎地沙坦酯与无机酸的脱保护来制备纯坎地沙坦酯。
-
公开(公告)号:US20090018344A1
公开(公告)日:2009-01-15
申请号:US12279226
申请日:2007-02-14
IPC分类号: C07D403/08
CPC分类号: C07D403/10
摘要: The invention relates to process for the preparation of Candesartan cilexetil. More particularly, it relates to the preparation of pure candesartan cilexetil by the deprotection of Trityl candesartan cilexetil with inorganic acids.
摘要翻译: 本发明涉及制备Candesartan cilexetil的方法。 更具体地说,它涉及通过三苯甲基坎地沙坦酯与无机酸的脱保护来制备纯坎地沙坦酯。
-
-
-
-
-
-
-
-